A Japanese pharmaceutical company prevailed Thursday in a Las Vegas case involving two women who claimed the diabetes drug Actos caused them to develop bladder cancer.
Courts
By CARRI GEER THEVENOT / RJ
Actos has been used for years to reduce blood-sugar levels in patients suffering from Type 2 diabetes, a lawyer for the drug’s manufacturer said Tuesday. It was the second and final day of closing arguments in a Las Vegas trial that began three months ago against Japanese company Takeda Pharmaceuticals.
MOST READ
1
2
3
4
5
‘It feels very lonely’: 80 years after D-Day, only 2 USS Nevada crew members remain
World’s No. 1 restaurant for 2024 crowned in Las Vegas
Poker legend suffers shocking bad beat, eliminated from WSOP event
Utah-born soda shop to open Las Vegas location
‘I’m not retiring’: Palms general manager steps down